Cargando…

Correction to: CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling

Detalles Bibliográficos
Autores principales:	Zhang, Jing, Hou, Lidan, Liang, Rui, Chen, Xiaoyu, Zhang, Rui, Chen, Wei, Zhu, Jinshui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7422531/ https://www.ncbi.nlm.nih.gov/pubmed/32787855 http://dx.doi.org/10.1186/s12943-020-01243-0

Ejemplares similares

CircDLST promotes the tumorigenesis and metastasis of gastric cancer by sponging miR-502-5p and activating the NRAS/MEK1/ERK1/2 signaling
por: Zhang, Jing, et al.
Publicado: (2019)

Astragaloside IV exhibits anti-tumor function in gastric cancer via targeting circRNA dihydrolipoamide S-succinyltransferase (circDLST)/miR-489-3p/ eukaryotic translation initiation factor 4A1(EIF4A1) pathway
por: Li, Fagen, et al.
Publicado: (2022)

CircSLC3A2 functions as an oncogenic factor in hepatocellular carcinoma by sponging miR-490-3p and regulating PPM1F expression
por: Wang, Hongjian, et al.
Publicado: (2018)

Oncogenic RAC1 and NRAS drive resistance to endoplasmic reticulum stress through MEK/ERK signalling
por: Bright, Michael D., et al.
Publicado: (2018)

EIF4A3-induced circular RNA ASAP1 promotes tumorigenesis and temozolomide resistance of glioblastoma via NRAS/MEK1/ERK1–2 signaling
por: Wei, Yutian, et al.
Publicado: (2020)

MEK1 is required for the development of NRAS-driven leukemia
por: Nowacka, Joanna D., et al.
Publicado: (2016)

SODD Promotes Lung Cancer Tumorigenesis by Activating the PDK1/AKT and RAF/MEK/ERK Signaling
por: Bao, Fan, et al.
Publicado: (2023)

MEK inhibitors for the treatment of NRAS mutant melanoma
por: Sarkisian, Saro, et al.
Publicado: (2018)

Circular RNA_LARP4 inhibits cell proliferation and invasion of gastric cancer by sponging miR-424-5p and regulating LATS1 expression
por: Zhang, Jing, et al.
Publicado: (2017)

Experimental treatment of NRAS-mutated neurocutaneous melanocytosis with MEK162, a MEK-inhibitor
por: Küsters-Vandevelde, Heidi VN, et al.
Publicado: (2014)

Molecular spectrum of BRAF, NRAS and KRAS gene mutations in plasma cell dyscrasias: implication for MEK-ERK pathway activation
por: Lionetti, Marta, et al.
Publicado: (2015)

DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling
por: Mellid, Sara, et al.
Publicado: (2023)

Combination of pan-RAF and MEK inhibitors in NRAS mutant melanoma
por: Atefi, Mohammad, et al.
Publicado: (2015)

CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma
por: Du, Jinpeng, et al.
Publicado: (2022)

LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway
por: Huang, Yanxia, et al.
Publicado: (2017)

Correction to: LncRNA AK023391 promotes tumorigenesis and invasion of gastric cancer through activation of the PI3K/Akt signaling pathway
por: Huang, Yanxia, et al.
Publicado: (2020)

Correction: CircNFIB inhibits tumor growth and metastasis through suppressing MEK1/ERK signaling in intrahepatic cholangiocarcinoma
por: Du, Jinpeng, et al.
Publicado: (2023)

Loss of dihydrolipoyl succinyltransferase (DLST) leads to reduced resting heart rate in the zebrafish
por: Keßler, Mirjam, et al.
Publicado: (2015)

Treatment of severe Kaposiform Lymphangiomatosis positive for NRAS mutation by MEK-inhibition
por: Chowers, Guy, et al.
Publicado: (2022)

DLST-dependence dictates metabolic heterogeneity in TCA-cycle usage among triple-negative breast cancer
por: Shen, Ning, et al.
Publicado: (2021)

CircRNA_0044556 diminishes the sensitivity of triple-negative breast cancer cells to adriamycin by sponging miR-145 and regulating NRAS
por: Chen, Jingjing, et al.
Publicado: (2022)

Combined inhibition of MEK and Plk1 has synergistic anti-tumor activity in NRAS mutant melanoma
por: Posch, C, et al.
Publicado: (2015)

Synthetic lethal interaction of cetuximab with MEK1/2 inhibition in NRAS-mutant metastatic colorectal cancer
por: Queralt, Bernardo, et al.
Publicado: (2016)

Hsa_circRNA_0084043 promoting tumorigenesis in glioma through miR-577 sponging
por: Qian, Jin, et al.
Publicado: (2023)

Biomarker results from a phase II study of MEK1/2 inhibitor binimetinib (MEK162) in patients with advanced NRAS- or BRAF-mutated melanoma
por: van Herpen, Carla M.L., et al.
Publicado: (2019)

MIG6 is MEK-regulated and affects EGF-induced migration in mutant NRAS melanoma
por: Vu, Ha Linh, et al.
Publicado: (2015)

KRAS and NRAS Translation Is Increased upon MEK Inhibitors-Induced Processing Bodies Dissolution
por: Vidal-Cruchez, Olivia, et al.
Publicado: (2023)

Circular RNA circPDSS1 promotes osteosarcoma progression by sponging miR-502-3p and miR-4436a
por: Tang, Shaolong, et al.
Publicado: (2021)

MEK5/ERK5 Signaling Suppresses Estrogen Receptor Expression and Promotes Hormone-Independent Tumorigenesis
por: Antoon, James W., et al.
Publicado: (2013)

MAGOH/MAGOHB Inhibits the Tumorigenesis of Gastric Cancer via Inactivation of b-RAF/MEK/ERK Signaling
por: Zhou, Yong, et al.
Publicado: (2020)

CircRNA CDR1as/miR-1287/Raf1 Axis Modulates Hepatocellular Carcinoma Progression Through MEK/ERK Pathway
por: Zhang, Bashan, et al.
Publicado: (2020)

Candidate drugs associated with sensitivity of cancer cell lines with DLST amplification or high mRNA levels
por: Kuhn, Christina, et al.
Publicado: (2023)

MYOD induced lnc-MEG3 promotes porcine satellite cell differentiation via interacting with DLST
por: Liu, Quan, et al.
Publicado: (2023)

HSP70 Inhibition Blocks Adaptive Resistance and Synergizes with MEK Inhibition for the Treatment of NRAS-Mutant Melanoma
por: Parris, Joshua L.D., et al.
Publicado: (2021)

MEK inhibition appears to improve symptom control in primary NRAS-driven CNS melanoma in children
por: Kinsler, Veronica A, et al.
Publicado: (2017)

Successful treatment with MEK‐inhibitor in a patient with NRAS ‐related cutaneous skeletal hypophosphatemia syndrome
por: Carli, Diana, et al.
Publicado: (2022)

Case report: Therapeutic potential of T-VEC in combination with MEK inhibitors in melanoma patients with NRAS mutation
por: Simon, Sonja C. S., et al.
Publicado: (2023)

CircCSNK1G1 Contributes to the Tumorigenesis of Gastric Cancer by Sponging miR-758 and Regulating ZNF217 Expression
por: Qiang, Feng, et al.
Publicado: (2021)

CircNT5E promotes the proliferation and migration of bladder cancer via sponging miR-502-5p
por: Yang, Jinhui, et al.
Publicado: (2021)

ERK1b, a 46‐kDa ERK isoform that is differentially regulated by MEK
por: Yung, Yuval, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fden10brsb929lmntn6b8j4l07